Carmen Kohler1, Ming Chang2, Yu-Yin Allemann-Su2, Marcus Vetter1, Miyeon Jung3, Misook Jung4, Yvette Conley5, Steven Paul6, Kord M Kober6, Bruce A Cooper6, Betty Smoot7, Jon D Levine7, Christine Miaskowski8, Maria C Katapodi9. 1. Medical Oncology, University Hospital Basel, Basel, Switzerland. 2. Department of Clinical Research, Nursing Science, University of Basel, Basel, Switzerland. 3. College of Nursing, Chungnam National University, Daejeon, South Korea. 4. School of Nursing, Indiana University, Indianapolis, Indiana, USA. 5. School of Nursing, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. 6. School of Nursing, University of California San Francisco, San Francisco, California, USA. 7. School of Medicine, University of California San Francisco, San Francisco, California, USA. 8. School of Nursing, University of California San Francisco, San Francisco, California, USA. Electronic address: chris.miaskowski@nursing.ucsf.edu. 9. Department of Clinical Research, Nursing Science, University of Basel, Basel, Switzerland; School of Nursing, University of Michigan, Ann Arbor, Michigan, USA.
Abstract
CONTEXT: Although approximately 75% of patients with breast cancer report changes in attentional function, little is known about how demographic, clinical, symptom, and psychosocial adjustment (e.g., coping) characteristics influence changes in the trajectories of attentional function over time. OBJECTIVES: This study evaluated interindividual variability in the trajectories of self-reported attentional function and determined which demographic, clinical, symptom, and psychosocial adjustment characteristics were associated with initial levels and with changes in attentional function from before through 12 months after breast cancer surgery. METHODS: Before surgery, 396 women were enrolled. Attentional Function Index (AFI) was completed before and nine times within the first 12 months after surgery. Hierarchical linear modeling was used to determine which characteristics were associated with initial levels and trajectories of attentional function. RESULTS: Given an estimated preoperative AFI score of 6.53, for each additional month, the estimated linear rate of change in AFI score was an increase of 0.054 (P < 0.001). Higher levels of comorbidity, receipt of adjuvant chemotherapy, higher levels of trait anxiety, fatigue, and sleep disturbance, and lower levels of energy and less sense of control were associated with lower levels of attentional function before surgery. Patients who had less improvements in attentional function over time were nonwhite, did not have a lymph node biopsy, had received hormonal therapy, and had less difficulty coping with their disease. CONCLUSION: Findings can be used to identify patients with breast cancer at higher risk for impaired self-reported cognitive function and to guide the prescription of more personalized interventions.
CONTEXT: Although approximately 75% of patients with breast cancer report changes in attentional function, little is known about how demographic, clinical, symptom, and psychosocial adjustment (e.g., coping) characteristics influence changes in the trajectories of attentional function over time. OBJECTIVES: This study evaluated interindividual variability in the trajectories of self-reported attentional function and determined which demographic, clinical, symptom, and psychosocial adjustment characteristics were associated with initial levels and with changes in attentional function from before through 12 months after breast cancer surgery. METHODS: Before surgery, 396 women were enrolled. Attentional Function Index (AFI) was completed before and nine times within the first 12 months after surgery. Hierarchical linear modeling was used to determine which characteristics were associated with initial levels and trajectories of attentional function. RESULTS: Given an estimated preoperative AFI score of 6.53, for each additional month, the estimated linear rate of change in AFI score was an increase of 0.054 (P < 0.001). Higher levels of comorbidity, receipt of adjuvant chemotherapy, higher levels of trait anxiety, fatigue, and sleep disturbance, and lower levels of energy and less sense of control were associated with lower levels of attentional function before surgery. Patients who had less improvements in attentional function over time were nonwhite, did not have a lymph node biopsy, had received hormonal therapy, and had less difficulty coping with their disease. CONCLUSION: Findings can be used to identify patients with breast cancer at higher risk for impaired self-reported cognitive function and to guide the prescription of more personalized interventions.
Authors: Debra E Lyon; Ronald Cohen; Huaihou Chen; Debra L Kelly; Angela Starkweather; Hyo-Chol Ahn; Colleen K Jackson-Cook Journal: J Cancer Res Clin Oncol Date: 2016-04-21 Impact factor: 4.553
Authors: Min Hae Park; Sarah C Smith; Jenny Neuburger; Theopisti Chrysanthaki; A A Jolijn Hendriks; Nick Black Journal: Alzheimer Dis Assoc Disord Date: 2017 Apr-Jun Impact factor: 2.703
Authors: K Ribi; J Aldridge; K-A Phillips; A Thompson; V Harvey; B Thürlimann; F Cardoso; O Pagani; A S Coates; A Goldhirsch; K N Price; R D Gelber; J Bernhard Journal: Br J Cancer Date: 2012-04-24 Impact factor: 7.640
Authors: Mahasin S Mujahid; Nancy K Janz; Sarah T Hawley; Jennifer J Griggs; Ann S Hamilton; John Graff; Steven J Katz Journal: J Cancer Surviv Date: 2010-10-09 Impact factor: 4.442
Authors: M L Gregorowitsch; A Ghedri; D A Young-Afat; R Bijlsma; I O Baas; C van Schaik-van de Mheen; M J Agterof; E Göker; D Ten Bokkel Huinink; H J G D van den Bongard; H M Verkooijen Journal: Breast Cancer Res Treat Date: 2019-02-12 Impact factor: 4.872
Authors: Niklas Paul Grusdat; Alexander Stäuber; Marion Tolkmitt; Jens Schnabel; Birgit Schubotz; Henry Schulz Journal: Oncol Res Treat Date: 2021-10-13 Impact factor: 2.825
Authors: Yu-Yin Allemann-Su; Marcus Vetter; Helen Koechlin; Steven M Paul; Bruce A Cooper; Kate Oppegaard; Michelle Melisko; Jon D Levine; Yvette Conley; Christine Miaskowski; Maria C Katapodi Journal: Cancers (Basel) Date: 2022-07-05 Impact factor: 6.575